Study on the efficacy and safety of ketamine in postoperative patient-controlled intravenous analgesia for spinal surgery patients: A randomized controlled study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400088111

Enrollment

Unknown

Registered

2024-08-12

Start date

2024-08-15

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Experimental group (ketamine group):Stop infusion of propofol and remifentanil approximately 10 minutes before the completion of the surgery, and connect the intravenous electronic patient-controlled

Control group (sufentanil group):Stop infusion of propofol and remifentanil approximately 10 minutes before the completion of the surgery, and connect the intravenous electronic patient-controlled ana

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patient has indications for spinal surgery, no history of drug allergies, no history of chronic pain or mental illness.

Exclusion criteria

Exclusion criteria: There are contraindications for the use of sufentanil and ketamine; Unable to cooperate with the researcher to complete this study.

Design outcomes

Primary

Measure	Time frame
Postoperative pain VAS scores at 12, 24, and 48 hours;	—

Secondary

Measure	Time frame
Postoperative recovery quality;Postoperative insomnia incidence rate;	—

Countries

China

Contacts

Public Contactche yingjie

Shihezi People's Hospital

751564366@qq.com+86 182 9907 2057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026